The Michael J. Fox Foundation for Parkinson's Research

62 articles with The Michael J. Fox Foundation for Parkinson's Research

• 

  Teva and MODAG Tie Up on Potential Parkinson's, MSA Treatment

  10/27/2021

  Teva Pharmaceuticals inked a deal with MODAG GmbH to license and develop two of MODAG’s compounds in neurodegenerative disease, anle138b and sery433.

• The Michael J. Fox Foundation Launches New Guide to Provide Insights and Practical Strategies for Spanish-Speaking Patients and Families on Navigating the Parkinson's Journey

  9/17/2021

  Newly translated resource in Spanish offers informative, candid first-hand reflections and practical strategies on understanding and living with Parkinson's disease

• California Funds Parkinson's Disease Registry with Advocacy and Support from The Michael J. Fox Foundation

  7/14/2021

  The Michael J. Fox Foundation for Parkinson's Research (MJFF) today commended California Governor Gavin Newsom for signing the state's FY 2021-2022 budget that includes $8.4 million to fund the California Parkinson's Disease Registry (CPDR) and to expand it to other neurodegenerative diseases over the next four years.

• The Michael J. Fox Foundation Releases New Guide, Deep Brain Stimulation and Parkinson's

  6/15/2021

  With an estimated 6 million people worldwide living with Parkinson's, and an estimated 60,000 newly diagnosed annually, resources to help navigate available treatments to manage Parkinson's care are critical.

• Michael J. Fox Foundation and 23andMe Share New Genetic Data from the Largest Cohort in Parkinson's Research

  6/8/2021

  Collaboration with 23andMe enables robust sharing of de-identified genetic data with researchers worldwide through the Fox Insight Data Exploration Network (Fox DEN)

• The Michael J. Fox Foundation for Parkinson's Research Adds Melanie Bolch Isbill, Alex Krys and Jack Quinn to Its Board of Directors

  4/20/2021

  The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced that during its Board meeting on March 11, 2021 , three new members were appointed to the Board of Directors — Melanie Bolch Isbill , Alex Krys and Jack Quinn.

• Clene Nanomedicine Awarded Michael J. Fox Foundation Grant to Accelerate the Development of CNM-Au8 as a Treatment for Parkinson’s Disease

  3/1/2021

  Interim data from a Phase 2 target engagement study show that CNM-Au8 treatment was associated with improvements across key CNS bioenergetic metabolites in Parkinson’s disease patients

• Yesse Technologies secures another grant from The Michael J. Fox Foundation to sniff out Parkinson's disease

  1/19/2021

  Yesse Technologies, Inc., a New York-headquartered biotechnology company, developing a technology platform to digitize the sense of smell, announces that it was awarded a $670,000 grant from The Michael J. Fox Foundation for Parkinson's Research.

• Sengenics Awarded Prestigious Michael J. Fox Foundation Grant to Determine the Role of Autoantibodies in the Progression of Parkinson’s

  12/15/2020

  Sengenics, the Functional Proteomics Company, has been awarded a prestigious research grant by The Michael J. Fox Foundation for Parkinson's Research (MJFF) to identify novel autoantibody signatures related to non-motor symptoms in individuals with high risk of Parkinson’s disease (PD) from the Parkinson’s Associated Risk Study (PARS). The objective of the study will be to leverage KREX-based Immunome protein arrays to identify a

• Michael J. Fox Foundation for Parkinson's Research Honored with Advocacy/Policy Award from Reagan-Udall Foundation for the FDA

  12/9/2020

  The Michael J. Fox Foundation for Parkinson's Research (MJFF) has received the Advocacy/Policy Award from the Reagan-Udall Foundation for the Food and Drug Administration. MJFF is the second organization ever to receive this award, which honors individuals or groups that have made an impact to improve public health through advocacy and p

• The Michael J. Fox Foundation for Parkinson's Research Confers the Edmond J. Safra Humanitarian Award on Lily Safra in Recognition of Leadership Philanthropy

  11/23/2020

  The Michael J. Fox Foundation for Parkinson's Research (MJFF) today announces it has created the Edmond J. Safra Humanitarian Award to honor Lily Safra , chairwoman of The Edmond J. Safra Foundation and a founding member of MJFF's Board of Directors. Mrs. Safra is a globally recognized philanthropist with a legacy of serving others thr

• Global charities join forces to drive forward new drug for Parkinson's

  11/23/2020

  Between 40 and 50 percent of people with Parkinson's will experience dyskinesia after just five years of taking levodopa. After ten years of taking the medication, this figure jumps to up to 80 percent

• Michael J. Fox Foundation Announces $380,000 In Funding To Extend The California Parkinson's Disease Registry Through June 2021

  11/12/2020

   The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced today it is granting $380,000 in extension funding to the California Parkinson's Disease Registry (CPDR) to be used through June 30, 2021 . The investment comes after Governor Gavin Newsom signed a bill to extend the registry by one year. The CPDR was created i

• The Michael J. Fox Foundation for Parkinson's Research Sponsors Virtual Educational Course to Cultivate Additional Parkinson's Clinicians

  10/12/2020

  Responding to the urgent need for additional specialists to treat the growing prevalence of people with Parkinson's disease (PD), the International Parkinson and Movement Disorder Society hosted the fifth annual " Pan American Section (MDS-PAS) Movement Disorders School for Neurology Residents " on October 10, 2020 . Sponsored by the Ed

• Cantabio Pharmaceuticals receives grant from Michael J. Fox Foundation to develop a novel DJ-1 protein-based biomarker for Parkinson's Disease

  9/16/2020

  Grant enables the development of new detection technologies for DJ-1 in biofluids to create a new biomarker for the potential early diagnosis and tracking of the progression of Parkinsons disease

• Michael J. Fox Foundation Announces Relaunch of Parkinson's Podcast

  8/20/2020

  Foundation Patient Council Member and veteran broadcaster Larry Gifford tapped to host monthly conversations on the latest advances in Parkinson's disease research and care   [20-August-2020]   NEW YORK and VANCOUVER, BC , Aug. 20, 2020 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) announces the re-launch of its Parkinson's Podcast — a mo

• The Michael J. Fox Foundation Launches Virtual 5K/10K to Meet Ambitious Fundraising Goal and Unite the Parkinson's Community

  8/19/2020

  - Runners and walkers of all ages, abilities and speeds are encouraged to participate from anywhere in this remote event - Learn more and register at foxtrot.org -- 100 percent of registration fees go directly to the critical research programs of The Michael J. Fox Foundation   [19-August-2020]   NEW YORK , Aug. 19, 2020 /PRNewswire/ -- The Michael J. Fox Founda

• The Michael J. Fox Foundation's Edmond J. Safra Fellowship in Movement Disorders Expands to Meet Growing Needs in Parkinson's Care and Research

  8/4/2020

  With an estimated 6 million people worldwide currently living with Parkinson's, and the disease prevalence expected to double by 2040, the need for more movement disorder specialists to provide expert care and lead research is pressing

• Michael J. Fox Foundation Announces Winners of the "Ken Griffin Alpha-synuclein Imaging Competition" to Develop Game-Changing Tool for Parkinson's Research

  7/30/2020

  Key milestone in scientific competition to spur the development of an imaging tracer to track Parkinson's pathology

• Axial Biotherapeutics Announces a Research Grant Award from The Michael J. Fox Foundation for the Development of an Enteric Nervous System Model to Assess Novel Parkinson’s Disease Therapeutics

  7/28/2020

  Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted therapeutics for neurodegenerative diseases and neurodevelopmental disorders, today announces it has received a research grant of $440,000 from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through its Therapeutic Pipeline Program. The award will enable development of a novel in vitro model system of the e